Venture Certified
| 기술평가대출기업(중진공) | 2016-06-02 ~ 2018-06-01 | 20160400863 | 2016-06-02 |
| 기술평가보증기업(기금) | 2018-06-02 ~ 2020-06-01 | 20180106382 | 2016-06-02 |
| 기술평가보증기업(기금) | 2020-06-02 ~ 2022-06-01 | 20200107095 | 2016-06-02 |
| 벤처투자유형 | 2022-06-02 ~ 2025-06-01 | 20220518010007 | 2016-06-02 |
| 벤처투자유형 | 2025-06-02 ~ 2028-06-01 | 20250513010016 | 2016-06-02 |
Revenue CAGR -54.9%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.0B | 0.6B | 1.2B |
| Operating Profit | -36.3B | -64.5B | -38.3B |
| Net Profit | -36.9B | -64.9B | -38.5B |
| Total Assets | 18.5B | 43.2B | 108.5B |
| Total Liabilities | 14.2B | 12.0B | 13.1B |
| Total Equity | 4.3B | 31.2B | 95.4B |
Operating Loss: Op. profit -36B
Revenue down 100% YoY
3 Consecutive Years of Net Loss
Debt Ratio Surge (+290pp YoY)
▼ 100.0%
▲ 29.5%
▲ 1157.5%
▼ 587.1%
| Name | Position | Role |
|---|---|---|
| 정승수 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "강원 춘천시",
"ceo_name": "정승수",
"certificate": [
{
"cert_number": "20160400863",
"changes": "",
"disclosure_date": "2016-06-02",
"first_cert_date": "2016-06-02",
"no": "1",
"type": "기술평가대출기업(중진공)",
"valid_period": "2016-06-02 ~ 2018-06-01"
},
{
"cert_number": "20180106382",
"changes": "",
"disclosure_date": "2018-05-28",
"first_cert_date": "2016-06-02",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2018-06-02 ~ 2020-06-01"
},
{
"cert_number": "20200107095",
"changes": "",
"disclosure_date": "2020-05-29",
"first_cert_date": "2016-06-02",
"no": "3",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-06-02 ~ 2022-06-01"
},
{
"cert_number": "20220518010007",
"changes": "",
"disclosure_date": "2022-05-18",
"first_cert_date": "2016-06-02",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2022-06-02 ~ 2025-06-01"
},
{
"cert_number": "20250513010016",
"changes": "",
"disclosure_date": "2025-05-13",
"first_cert_date": "2016-06-02",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2025-06-02 ~ 2028-06-01"
}
],
"company_name": "(주)비엔에이치리서치",
"corp_no": "285011-*******",
"financials": {
"2022": {
"capital_stock": 107719000,
"cost_of_sales": 0,
"current_assets": 9224906000,
"current_liabilities": 1307941000,
"gross_profit": 122000000,
"net_income": -3846519000,
"net_income_bs": -3846520000,
"non_current_assets": 1626090000,
"non_current_liabilities": 5540000,
"non_operating_expenses": 47118000,
"non_operating_income": 32221000,
"operating_profit": -3831622000,
"revenue": 122000000,
"sga_expenses": 3953622000,
"total_assets": 10850995000,
"total_equity": 9537514000,
"total_liabilities": 1313481000
},
"2023": {
"capital_stock": 108806000,
"cost_of_sales": 0,
"current_assets": 2779387000,
"current_liabilities": 1200556000,
"gross_profit": 55000000,
"net_income": -6493120000,
"net_income_bs": -6493120000,
"non_current_assets": 1542558000,
"non_current_liabilities": 0,
"non_operating_expenses": 61249000,
"non_operating_income": 16777000,
"operating_profit": -6448648000,
"revenue": 55000000,
"sga_expenses": 6503648000,
"total_assets": 4321945000,
"total_equity": 3121389000,
"total_liabilities": 1200556000
},
"2024": {
"capital_stock": 110561000,
"cost_of_sales": 0,
"current_assets": 443198000,
"current_liabilities": 1420019000,
"gross_profit": 0,
"net_income": -3688733000,
"net_income_bs": -3688733000,
"non_current_assets": 1409182000,
"non_current_liabilities": 0,
"non_operating_expenses": 64880000,
"non_operating_income": 1884000,
"operating_profit": -3625737000,
"revenue": 0,
"sga_expenses": 3625737000,
"total_assets": 1852380000,
"total_equity": 432361000,
"total_liabilities": 1420019000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "2,000,139,100",
"changes": "2,000,139,100",
"date": "2024-05-23"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2022-03-18"
},
{
"amount": "2,000,000,000",
"changes": "2,000,000,000",
"date": "2022-03-18"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2022-03-18"
},
{
"amount": "3,000,000,000",
"changes": "3,000,000,000",
"date": "2022-03-18"
},
{
"amount": "3,000,000,000",
"changes": "3,000,000,000",
"date": "2022-03-18"
},
{
"amount": "500,000,000",
"changes": "500,000,000",
"date": "2020-05-26"
},
{
"amount": "500,000,000",
"changes": "500,000,000",
"date": "2020-05-26"
},
{
"amount": "1,500,000,000",
"changes": "1,500,000,000",
"date": "2020-05-13"
},
{
"amount": "200,000,000",
"changes": "200,000,000",
"date": "2019-03-29"
},
{
"amount": "300,000,000",
"changes": "300,000,000",
"date": "2017-04-26"
}
],
"main_products": "신약개발 및 약물효능평가 서비스",
"phone": "704-366-****",
"years": [
2024,
2023,
2022
]
}